Principal Financial Group Inc. boosted its stake in Clorox Co. (NYSE:CLX) by 1.2% during the third quarter, Holdings Channel reports. The fund owned 214,414 shares of the company’s stock after buying an additional 2,616 shares during the period. Principal Financial Group Inc. owned about 0.17% of Clorox worth $26,840,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Valley National Advisers Inc. raised its position in Clorox by 0.5% in the third quarter. Valley National Advisers Inc. now owns 849 shares of the company’s stock valued at $106,000 after buying an additional 4 shares during the last quarter. Carroll Financial Associates Inc. raised its position in Clorox by 0.4% in the third quarter. Carroll Financial Associates Inc. now owns 3,361 shares of the company’s stock valued at $420,000 after buying an additional 12 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its position in Clorox by 0.7% in the third quarter. Bronfman E.L. Rothschild L.P. now owns 1,878 shares of the company’s stock valued at $235,000 after buying an additional 13 shares during the last quarter. Rowland & Co. Investment Counsel ADV raised its position in Clorox by 0.4% in the third quarter. Rowland & Co. Investment Counsel ADV now owns 3,871 shares of the company’s stock valued at $485,000 after buying an additional 14 shares during the last quarter. Finally, Financial Advisory Service Inc. raised its position in Clorox by 0.3% in the third quarter. Financial Advisory Service Inc. now owns 5,256 shares of the company’s stock valued at $658,000 after buying an additional 16 shares during the last quarter. 69.44% of the stock is owned by institutional investors.
Shares of Clorox Co. (NYSE:CLX) opened at 120.91 on Thursday. The stock’s 50 day moving average price is $118.64 and its 200-day moving average price is $124.11. Clorox Co. has a 52 week low of $111.24 and a 52 week high of $140.47. The stock has a market cap of $15.57 billion, a price-to-earnings ratio of 24.34 and a beta of 0.33.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $1.36 earnings per share for the quarter, missing analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Clorox had a return on equity of 250.82% and a net margin of 11.27%. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.32 earnings per share. Equities analysts anticipate that Clorox Co. will post $5.33 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 10th. Stockholders of record on Wednesday, January 25th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.65%. The ex-dividend date is Monday, January 23rd. Clorox’s dividend payout ratio is presently 64.26%.
Several analysts have recently weighed in on the company. B. Riley reiterated a “neutral” rating and set a $123.00 target price on shares of Clorox in a research report on Monday, December 5th. Morgan Stanley upgraded Clorox from an “underweight” rating to an “equal weight” rating and set a $112.00 target price for the company in a research report on Friday, December 16th. They noted that the move was a valuation call. Royal Bank Of Canada decreased their target price on Clorox from $121.00 to $115.00 and set a “sector perform” rating for the company in a research report on Thursday, November 3rd. Barclays PLC upgraded Clorox from an “underweight” rating to an “equal weight” rating and decreased their target price for the stock from $115.00 to $111.00 in a research report on Monday, January 9th. Finally, Zacks Investment Research downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average price target of $126.75.
In other Clorox news, Director A D. David Mackay purchased 5,000 shares of the stock in a transaction dated Thursday, December 1st. The stock was acquired at an average cost of $114.90 per share, for a total transaction of $574,500.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.74% of the company’s stock.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).